HMG-CoA Reductase

HMG-CoA Reductase

HMG-CoA Reductase (HMGCR) is the rate-limiting enzyme for cholesterol synthesis in the conversion of HMG-CoA to mevalonate.Eukaryotes and prokaryotes both contain HMGCR. Two classes of HMG-CoA reductase have been identified through phylogenetic analysis: Class I enzymes found in some eukaryotes and archaea and Class II enzymes found in some eubacteria and other archaea.

The enzyme HMGCR is known to catalyze an early reaction specific to isoprenoid biosynthesis in both eukaryotes and archaebacteria. Drugs used to lower serum cholesterol levels frequently target the HMG-CoA reductase reaction because it is rate-limiting for the biosynthesis of cholesterol in humans.

HMG-CoA Reductase related products

Structure Cat No. Product Name CAS No. Product Description
V0928 Atorvastatin Calcium 134523-03-8 Atorvastatin Calcium (CI-981; CI981; Atorvastatin hemicalcium; liptonorm),an approved blockbuster drug of the statin class of LDL cholesterol-lowering/hypolipidemic medications, is a potent and selectiveinhibitor of HMG-CoA reductase with anti-hyperlipidemic effects.
V0930 Clinofibrate 30299-08-2 Clinofibrate (Lipoclin; S-8527; S 8527) is a potent anti-hyperlipidemic agent which acts as an HMG-CoA (hydroxymethylglutaryl coenzyme A) reductase inhibitorwith potential anti-hyperlipidemic effects.
V0927 Fluvastatin Sodium 93957-55-2 Fluvastatin (XU-62320;Fluindostatin; Lescol XL;XU-62-320; Canef; Lipaxan; Vastin), an approved drug belonging to the statin class of hypolipidemic medications, is a potent inhibitor of HMG-CoA reductase activity with potential anti-hyperlipidemic effects.
V0926 Lovastatin 75330-75-5 Lovastatin (Mevinolin; Mevacor;MK-803; Altoprev; Monacolin K; MK803), belonging to the statin class of hypolipidemic agent/lipid-lowering drugs,isa potent andcell-permeableinhibitor of HMG-CoA reductase with potential anti-hyperlipidemic effects.
V0931 Mevastatin 73573-88-3 Mevastatin (CS500;ML236B; Mevastatin; Compactin;ML-236B),an approved anti-hyperliperdemic drug of the statin class, is a potent and competitive inhibitor of HMG-Coenzyme A (HMG-CoA) reductase with anti-hyperlipidemic effects.
V0929 Pravastatin sodium 81131-70-6 Pravastatin sodium (Apotex;CS-514; Pravachol; Pravaselect; Apo-Pravastatin;Mevalotin; Elisor; Lipostat), an approved hypolipidemic drug of the statin class, is an HMG-CoA reductase inhibitor against sterol synthesis with potential anti-hyperlipidemic effects.
V3294 Rosuvastatin 287714-41-4 Rosuvastatin (S-4522; ZD-4522;S4522; ZD4522; trade name: Crestor) is a member of the statin class of antihyperlipidemic drugs which acts as a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM in a cell-free assay.
V0925 Rosuvastatin Calcium 147098-20-2 Rosuvastatin Calcium (S-4522,Rosuvastatin hemicalcium; ZD-4522; ZD4522, trade name: Crestor), a member of the statin class of lipid-lowering drugs, is a potent and competitive inhibitor of HMG-CoA reductase with potential anti-hyperlipidemic activity.
V3295 Rosuvastatin D3 Sodium 1279031-70-7 Rosuvastatin D3 Sodium is deuterium labeled Rosuvastatin (also known as S-4522 and ZD 4522, trade name: Crestor) which is a member of the statin class of drugs and a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM in a cell-free assay.
V0924 Simvastatin 79902-63-9 Simvastatin (MK0733, Zocor; Synvinolin; Sinvacor;MK-0733; SIM), a marketed anti-hyperlipidemic drug of the statin class, is a lactone prodrug that has to be activated through hydrolysis to the active β-hydroxy acid form, which then acts as a potent andcompetitive inhibitor of HMG-CoA (3-hydroxy-3-methyl glutaryl coenzyme A) reductase with Ki of 0.1-0.2 nM in cell-free assays.
Contact Us Back to top